In conclusion, we reported the association of HRGs with patient prognosis in melanoma and screened for novel gene signatures, including FBP1, NDRG1, GPI, IER3, B4GALNT2, BGN, PKP1, and EDN2. This evidence concerns the gene FBP1 and melanoma.